VIA Pharmaceuticals ^Private

VIA Pharmaceuticals is a biotechnology company that specializes in developing small-molecule drugs to treat cardiovascular diseases. Their main goal is to reduce inflammation in the blood vessel wall, which is a major cause of atherosclerosis and its complications such as heart attack and stroke. VIA Pharmaceuticals is known for its innovative pipeline of drugs that target this unmet medical need. Their achievements include advancements in the field of cardiovascular medicine and the potential to improve the lives of patients suffering from cardiovascular diseases.